Screening and surveillance of venous stenosis in AVG: Is it time to rethink our assumptions?
- PMID: 34763539
- DOI: 10.1177/11297298211055611
Screening and surveillance of venous stenosis in AVG: Is it time to rethink our assumptions?
Abstract
Guidelines make no firm recommendations about surveillance of arteriovenous grafts as several randomised trials (RCT) have not shown a clear benefit in patency. However a more thorough review of these RCT based on epidemiological principles reveals significant limitations. In particular a key weakness of these older studies is the interventions performed for venous stenosis detected that was largely angioplasty. However, the observational data of modern stent-grafts shows a clear benefit over angioplasty, and thus seems to suggest that a modern well considered RCT is now mandated.
Keywords: Surveillance; arteriovenous graft; randomised trials; vascular access; venous stenosis.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: D. Kingsmore, P. Thomson, K. Stevenson – honoraria and research support from WL Gore, Proteon Therapeutics and have contributed to industry-funded research with Humacyte, Merit Medical.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
